Chemotherapy Research Today is a free monthly online journal that collates and summarizes the latest research about Chemotherapy, including details on cancer treatment, side effects, drugs.

The cost-effectiveness of bortezomib in relapsed/refractory multiple myeloma: Swedish perspective.

Hornberger J, Rickert J, Dhawan R, Liwing J, Aschan J, Löthgren M

Cedar Associates LLC, Menlo Park, CA, USA. ujch@stanford.edu

Published 12 November 2010 in Eur J Haematol, 85(6): 484-91.
Full-text of this article is available online (may require subscription).

© 2004-2012 Chemotherapy Research Today. All Rights Reserved.